SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-042815
Filing Date
2022-04-05
Accepted
2022-04-05 16:46:57
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2211420-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2211420-3_4seq1.xml 4 3488
  Complete submission text file 0001104659-22-042815.txt   4847
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA FORT LEE NJ 07024
Business Address
Poradosu Enrique (Reporting) CIK: 0001898147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 22807713